Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Region    |    News By Date    |    Business Directory
All Press Releases for August 06, 2009 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



GenScript Upgrades Plasmid Production Platform to Deliver Potent Plasmids
GenScript upgrades its plasmid production platform to enable wider scope downstream applications. 
x-small text small text medium text large text


    PISCATAWAY, NJ, August 06, 2009 /24-7PressRelease/ -- International life science contract research organization (CRO) GenScript USA Inc. has upgraded its plasmid preparation platform with an intention to better serve our customers¡¯ needs for demanding downstream applications. The upgrade produces premium plasmids for high efficient transfection, smooth DNA vaccination, and antibody production.

GenScript¡¯s new plasmid grades as a result of the upgrade are highly supercoiled (SC ¡İ 95% for SC Grade and Advanced SC Grade) with ultra-low levels of endotoxin (¡Ü 0.005 EU/¦Ìg for Advanced SC Grade). The upgrade includes rigorous quality control and complete enzyme-free plasmid production process. In addition, DNA shearing is minimized to ensure plasmid integrity and its suitability for standard downstream applications without requirement for further manipulation.

GenScript¡¯s gene services ranges from gene synthesis, cloning, to advanced engineering and library construction. To date, the company holds a record of having synthesized over one hundred thousand genes, including genes of over 50,000 bp in length and numbers of complex genes.

GenScript is a contract research organization (CRO) specialized in biological research and drug discovery services. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development. The renowned one-stop bio-reagent services include custom gene synthesis and molecular biology, custom protein expression and purification, custom peptide synthesis, antibody production, and custom cell line development. Headquartered in Piscataway, New Jersey, GenScript has become a world-leading Biology CRO and the largest gene synthesis supplier in the USA, with subsidiaries in France, Japan, and China.



For further information, please contact:
Sally Wang
Executive Vice President
GENSCRIPT USA INC.
1-732-885-9188
sallyw2@genscript.com


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #


Read more Press Releases from Sally Wang:
Other Press Release Headlines:


Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Press Release Contact Information:
Sally Wang
GenScript USA Inc.

Executive Vice President
120 Centennial Ave.
Piscataway,, New Jersey
Unites States 08854
Voice: 1-732-885-9188
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.